We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+11.4%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$361M
AUM Growth
+$13.5M
Cap. Flow
+$2.7M
Cap. Flow %
0.75%
Top 10 Hldgs %
38.32%
Holding
92
New
22
Increased
23
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$12.1M
2
CNC icon
Centene
CNC
+$9.16M
3
BIIB icon
Biogen
BIIB
+$9M
4
ABT icon
Abbott
ABT
+$8.96M
5
AMED
Amedisys
AMED
+$8.04M

Top Sells

Rank Stock Value
1
ARNA
Arena Pharmaceuticals Inc
ARNA
+$17.9M
2
MDT icon
Medtronic
MDT
+$10M
3
HOLX
Hologic
HOLX
+$8.86M
4
ZBH icon
Zimmer Biomet
ZBH
+$8.78M
5
ACHC icon
Acadia Healthcare
ACHC
+$8.05M

Sector Composition

Rank Sector Weight
1 Healthcare 97.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
1
Centene
CNC
$31.5B
$18.5M 5.13%
225,000
+125,000
+125% +$9.16M
SAGE
2
DELISTED
Sage Therapeutics
SAGE
$17.4M 4.81%
409,000
+90,000
+28% +$3.77M
CYTK icon
3
Cytokinetics
CYTK
$10.4B
$14.8M 4.1%
325,000
– –
RVTY icon
4
Revvity
RVTY
$12.9B
$14.1M 3.89%
70,000
+20,000
+40% +$3.62M
MCK icon
5
McKesson
MCK
$96.8B
$13.7M 3.78%
+55,000
New +$12.1M
NVST icon
6
Envista
NVST
$4.45B
$13.5M 3.74%
300,000
+70,000
+30% +$2.88M
GMED icon
7
Globus Medical
GMED
$11.1B
$13M 3.6%
180,000
+30,000
+20% +$2.18M
PFE icon
8
Pfizer
PFE
$143B
$11.8M 3.27%
200,000
-50,000
-20% -$2.48M
ELV icon
9
Elevance Health
ELV
$83B
$11.6M 3.21%
25,000
– –
ZNTL icon
10
Zentalis Pharmaceuticals
ZNTL
$331M
$10.1M 2.79%
120,000
+30,000
+33% +$2.32M
ABT icon
11
Abbott
ABT
$185B
$9.85M 2.73%
+70,000
New +$8.96M
CVS icon
12
CVS Health
CVS
$134B
$8.77M 2.43%
85,000
-65,000
-43% -$6.01M
BIIB icon
13
Biogen
BIIB
$29.8B
$8.4M 2.32%
+35,000
New +$9M
AMED
14
DELISTED
Amedisys
AMED
$8.09M 2.24%
+50,000
New +$8.04M
BPMC
15
DELISTED
Blueprint Medicines
BPMC
$8.03M 2.22%
75,000
-23,000
-23% -$2.41M
FATE icon
16
Fate Therapeutics
FATE
$291M
$7.61M 2.1%
130,000
+35,000
+37% +$1.98M
ACHC icon
17
Acadia Healthcare
ACHC
$2.85B
$7.28M 2.02%
120,000
-135,000
-53% -$8.05M
CCXI
18
DELISTED
ChemoCentryx, Inc.
CCXI
$7.28M 2.02%
200,000
-100,000
-33% -$3.51M
RLAY icon
19
Relay Therapeutics
RLAY
$4.09B
$6.91M 1.91%
225,000
+85,000
+61% +$2.69M
HRTX icon
20
Heron Therapeutics
HRTX
$96.8M
$6.85M 1.89%
750,000
+340,000
+83% +$3.47M
ABBV icon
21
AbbVie
ABBV
$433B
$6.77M 1.87%
50,000
+15,000
+43% +$1.77M
THC icon
22
Tenet Healthcare
THC
$20.1B
$6.54M 1.81%
+80,000
New +$5.85M
LH icon
23
Labcorp
LH
$24.9B
$6.28M 1.74%
+23,280
New +$5.76M
NTLA icon
24
Intellia Therapeutics
NTLA
$1.5B
$5.91M 1.64%
50,000
– –
EW icon
25
Edwards Lifesciences
EW
$51.1B
$5.83M 1.61%
45,000
+10,000
+29% +$1.17M
1
2 3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Integral Health Asset Management held 92 positions worth $361M, up 3.9% from $348M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Integral Health Asset Management's Q4 2021 filing shows 22 new, 23 increased, 17 reduced and 21 closed positions. Its largest new stake was McKesson: 55,000 shares worth $13.7M. The largest sale was Arena Pharmaceuticals Inc, an estimated $17.9M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

  • Integral Health Asset Management's largest Q4 2021 buy was McKesson: 55,000 shares worth $13.7M.
  • Integral Health Asset Management added most to Centene in Q4 2021, an estimated $9.16M increase.
  • Integral Health Asset Management's biggest Q4 2021 reduction was Acadia Healthcare, cutting an estimated $8.05M.
  • Integral Health Asset Management fully exited Arena Pharmaceuticals Inc in Q4 2021, selling an estimated $17.9M.
  • Integral Health Asset Management's ten largest holdings make up 38% of its $361M portfolio in Q4 2021.
  • Integral Health Asset Management opened 22 new positions and closed 21 in Q4 2021.
  • Integral Health Asset Management's portfolio value rose 3.9% quarter-over-quarter to $361M.

Based on Integral Health Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.